Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.610
+0.290 (12.50%)
At close: Aug 13, 2025, 4:00 PM
2.670
+0.060 (2.30%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $893.33 million as of August 14, 2025. Its market cap has increased by 0.35% in one year.
Market Cap
893.33M
Enterprise Value
343.37M
1-Year Change
0.35%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $893.33M, an increase of 412.00%. That is a compound annual growth rate of 38.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 893.33M | -0.22% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.66B |
| Johnson & Johnson | 419.17B |
| AbbVie | 350.80B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.95B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.64B |
| Novo Nordisk | 222.88B |